{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:17:14Z","timestamp":1793085434768,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00520-020-05336-w","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T07:02:51Z","timestamp":1582268571000},"page":"5235-5242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-1369","authenticated-orcid":false,"given":"G\u00f6k\u00e7e","family":"Kenar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-4444","authenticated-orcid":false,"given":"Elif Berna","family":"K\u00f6ksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-9887","authenticated-orcid":false,"given":"Y\u00fcksel","family":"\u00dcr\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8445-6993","authenticated-orcid":false,"given":"G\u00fcng\u00f6r","family":"Utkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"issue":"Suppl 7A","key":"5336_CR1","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(Suppl 7A):11S\u201326S. https:\/\/doi.org\/10.1016\/j.amjmed.2003.12.008","journal-title":"Am J Med"},{"issue":"4","key":"5336_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00000421-200208000-00011","volume":"25","author":"F Tas","year":"2002","unstructured":"Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A, Bulutlar G, Camlica H, Aydiner A, Topuz E (2002) Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol 25(4):371\u2013379","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"5336_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0889-8588(05)70342-7","volume":"10","author":"AR Moliterno","year":"1996","unstructured":"Moliterno AR, Spivak JL (1996) Anemia of cancer. Hematol Oncol Clin North Am 10(2):345\u2013363","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 7","key":"5336_CR4","doi-asserted-by":"publisher","first-page":"vii167","DOI":"10.1093\/annonc\/mdq284","volume":"21","author":"M Dicato","year":"2010","unstructured":"Dicato M, Plawny L, Diederich M (2010) Anemia in cancer. Ann Oncol 21(Suppl 7):vii167\u2013vii172. https:\/\/doi.org\/10.1093\/annonc\/mdq284","journal-title":"Ann Oncol"},{"issue":"4","key":"5336_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000065660","volume":"108","author":"K Ohneda","year":"2002","unstructured":"Ohneda K, Yamamoto M (2002) Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol 108(4):237\u2013245. https:\/\/doi.org\/10.1159\/000065660","journal-title":"Acta Haematol"},{"issue":"12","key":"5336_CR6","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0301-472X(00)00553-1","volume":"28","author":"P Ikonomi","year":"2000","unstructured":"Ikonomi P, Rivera CE, Riordan M, Washington G, Schechter AN, Noguchi CT (2000) Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol 28(12):1423\u20131431","journal-title":"Exp Hematol"},{"issue":"Suppl 1","key":"5336_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1054\/bjoc.2001.1750","volume":"84","author":"GD Demetri","year":"2001","unstructured":"Demetri GD (2001) Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 84(Suppl 1):31\u201337. https:\/\/doi.org\/10.1054\/bjoc.2001.1750","journal-title":"Br J Cancer"},{"issue":"6","key":"5336_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdh235","volume":"15","author":"D Cella","year":"2004","unstructured":"Cella D, Kallich J, McDermott A, Xu X (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15(6):979\u2013986","journal-title":"Ann Oncol"},{"issue":"15","key":"5336_CR9","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D (2004) The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40(15):2293\u20132306. https:\/\/doi.org\/10.1016\/j.ejca.2004.06.019","journal-title":"Eur J Cancer"},{"key":"5336_CR10","doi-asserted-by":"publisher","first-page":"7606128","DOI":"10.1155\/2019\/7606128","volume":"2019","author":"XZ Huang","year":"2019","unstructured":"Huang XZ, Yang YC, Chen Y, Wu CC, Lin RF, Wang ZN, Zhang X (2019) Preoperative anemia or low hemoglobin predicts poor prognosis in gastric cancer patients: a meta-analysis. Dis Markers 2019:7606128. https:\/\/doi.org\/10.1155\/2019\/7606128","journal-title":"Dis Markers"},{"issue":"7","key":"5336_CR11","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1158\/1078-0432.CCR-07-2068","volume":"14","author":"P Dubsky","year":"2008","unstructured":"Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stoger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Potter R, Gnant M, Austrian B, Colorectal Cancer Study G (2008) Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide\/methotrexate\/5-fluorouracil chemotherapy. Clin Cancer Res 14(7):2082\u20132087. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-2068","journal-title":"Clin Cancer Res"},{"issue":"12","key":"5336_CR12","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91(12):2214\u20132221","journal-title":"Cancer"},{"issue":"Supplement_4","key":"5336_CR13","doi-asserted-by":"publisher","first-page":"iv271","DOI":"10.1093\/annonc\/mdy323","volume":"29","author":"M Aapro","year":"2018","unstructured":"Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascon P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Osterborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J, Committee EG (2018) Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(Supplement_4):iv271. https:\/\/doi.org\/10.1093\/annonc\/mdy323","journal-title":"Ann Oncol"},{"key":"5336_CR14","unstructured":"Network NCC (2018) NCCN practice guidelines in oncology; cancer and chemotherapy-induced Anemia--v.3.2018"},{"issue":"20","key":"5336_CR15","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1182\/blood-2010-08-300541","volume":"116","author":"JD Rizzo","year":"2010","unstructured":"Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, Spivak JL, Bennett CL, Bohlius J, Evanchuk D, Goode MJ, Jakubowski AA, Regan DH, Somerfield MR, American Society of H, the American Society of Clinical Oncology Practice Guideline Update C (2010) American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116(20):4045\u20134059. https:\/\/doi.org\/10.1182\/blood-2010-08-300541","journal-title":"Blood"},{"key":"5336_CR16","doi-asserted-by":"publisher","unstructured":"Singh N, Baldi M, Kaur J, Muthu V, Prasad KT, Behera D, Bal A, Gupta N, Kapoor R (2019) Timing of folic acid\/vitamin B12 supplementation and hematologic toxicity during first-line treatment of patients with nonsquamous non-small cell lung cancer using pemetrexed-based chemotherapy: the PEMVITASTART randomized trial. Cancer. https:\/\/doi.org\/10.1002\/cncr.32028","DOI":"10.1002\/cncr.32028"},{"issue":"4","key":"5336_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1017\/S1368980008002401","volume":"12","author":"E McLean","year":"2009","unstructured":"McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B (2009) Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 12(4):444\u2013454. https:\/\/doi.org\/10.1017\/S1368980008002401","journal-title":"Public Health Nutr"},{"issue":"5","key":"5336_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.6004\/jnccn.2012.0064","volume":"10","author":"GM Rodgers 3rd","year":"2012","unstructured":"Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, Matulonis UA, Millenson MM, Reinke D, Rosenthal J, Schwartz RN, Soff G, Stein RS, Vlahovic G, Weir AB 3rd (2012) Cancer- and chemotherapy-induced anemia. J Natl Compr Cancer Netw 10(5):628\u2013653","journal-title":"J Natl Compr Cancer Netw"},{"issue":"10","key":"5336_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4103\/0019-5359.44022","volume":"62","author":"A Bahl","year":"2008","unstructured":"Bahl A, Sharma DN, Basu J, Rath GK, Julka PK (2008) Pre-treatment anemia evaluation in cancer patients attending radiotherapy clinic: results from a single Indian center. Indian J Med Sci 62(10):417\u2013420. https:\/\/doi.org\/10.4103\/0019-5359.44022","journal-title":"Indian J Med Sci"},{"issue":"11","key":"5336_CR20","first-page":"2825","volume":"12","author":"F Gao","year":"2011","unstructured":"Gao F, Cheng K, Zhao F, Chen Y, Li LH, Dong H, Men HT, Ge J, Tang J, Ding J, Chen X, Su JM, Liu JY (2011) Prevalence and characteristics of anemia in patients with solid cancers at diagnosis in Southwest China. Asian Pac J Cancer Prev 12(11):2825\u20132828","journal-title":"Asian Pac J Cancer Prev"},{"key":"5336_CR21","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1038\/nrdp.2017.40","volume":"3","author":"R Green","year":"2017","unstructured":"Green R, Allen LH, Bjorke-Monsen AL, Brito A, Gueant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C (2017) Vitamin B12 deficiency. Nat Rev Dis Primers 3:17040. https:\/\/doi.org\/10.1038\/nrdp.2017.40","journal-title":"Nat Rev Dis Primers"},{"key":"5336_CR22","doi-asserted-by":"publisher","first-page":"8279789","DOI":"10.1155\/2019\/8279789","volume":"2019","author":"E Kifle","year":"2019","unstructured":"Kifle E, Hussein M, Alemu J, Tigeneh W (2019) Prevalence of anemia and associated factors among newly diagnosed patients with solid malignancy at Tikur Anbessa specialized hospital, radiotherapy center, Addis Ababa, Ethiopia. Adv Hematol 2019:8279789. https:\/\/doi.org\/10.1155\/2019\/8279789","journal-title":"Adv Hematol"},{"issue":"2","key":"5336_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ajh.23628","volume":"89","author":"JA Gilreath","year":"2014","unstructured":"Gilreath JA, Stenehjem DD, Rodgers GM (2014) Diagnosis and treatment of cancer-related anemia. Am J Hematol 89(2):203\u2013212. https:\/\/doi.org\/10.1002\/ajh.23628","journal-title":"Am J Hematol"},{"issue":"8","key":"5336_CR24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.6004\/jnccn.2014.0104","volume":"12","author":"JA Gilreath","year":"2014","unstructured":"Gilreath JA, Rodgers GM (2014) Current quandaries in cancer-associated anemia. J Natl Compr Cancer Netw 12(8):1071\u20131075","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3 Suppl 2","key":"5336_CR25","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2146\/ajhp060601","volume":"64","author":"RN Schwartz","year":"2007","unstructured":"Schwartz RN (2007) Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm 64(3 Suppl 2):S5\u2013S13; quiz S28-30. https:\/\/doi.org\/10.2146\/ajhp060601","journal-title":"Am J Health Syst Pharm"},{"key":"5336_CR26","first-page":"351","volume":"4","author":"DDN Henry","year":"2007","unstructured":"Henry DDN (2007) Iron or vitamin B12 deficiency in anemic cancer patients prior to erythropoiesis stimulating agent therapy. Commun Oncol 4:351\u2013356","journal-title":"Commun Oncol"},{"issue":"7","key":"5336_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/bjc.2012.42","volume":"106","author":"M Aapro","year":"2012","unstructured":"Aapro M, Jelkmann W, Constantinescu SN, Leyland-Jones B (2012) Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer 106(7):1249\u20131258. https:\/\/doi.org\/10.1038\/bjc.2012.42","journal-title":"Br J Cancer"},{"issue":"3","key":"5336_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/ajcn\/86.3.718","volume":"86","author":"CM Pfeiffer","year":"2007","unstructured":"Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J, Osterloh JD (2007) Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. Am J Clin Nutr 86(3):718\u2013727. https:\/\/doi.org\/10.1093\/ajcn\/86.3.718","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"5336_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ijc.20648","volume":"113","author":"MA Sanjoaquin","year":"2005","unstructured":"Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113(5):825\u2013828. https:\/\/doi.org\/10.1002\/ijc.20648","journal-title":"Int J Cancer"},{"issue":"9","key":"5336_CR30","doi-asserted-by":"publisher","first-page":"e45979","DOI":"10.1371\/journal.pone.0045979","volume":"7","author":"JF Arendt","year":"2012","unstructured":"Arendt JF, Nexo E (2012) Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS One 7(9):e45979. https:\/\/doi.org\/10.1371\/journal.pone.0045979","journal-title":"PLoS One"},{"issue":"23","key":"5336_CR31","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/jnci\/djt315","volume":"105","author":"JF Arendt","year":"2013","unstructured":"Arendt JF, Pedersen L, Nexo E, Sorensen HT (2013) Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst 105(23):1799\u20131805. https:\/\/doi.org\/10.1093\/jnci\/djt315","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"5336_CR32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1158\/1055-9965.EPI-17-1136","volume":"28","author":"JFH Arendt","year":"2019","unstructured":"Arendt JFH, Sorensen HT, Horsfall LJ, Petersen I (2019) Elevated vitamin B12 levels and cancer risk in UK primary care: a THIN database cohort study. Cancer Epidemiol Biomark Prev 28(4):814\u2013821. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-1136","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9871","key":"5336_CR33","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S0140-6736(12)62001-7","volume":"381","author":"SE Vollset","year":"2013","unstructured":"Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bonaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF, Giovannucci EL, den Heijer M, Ueland PM, Bennett D, Collins R, Peto R, Collaboration BVTT (2013) Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 381(9871):1029\u20131036. https:\/\/doi.org\/10.1016\/S0140-6736(12)62001-7","journal-title":"Lancet"},{"issue":"14","key":"5336_CR34","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644. https:\/\/doi.org\/10.1200\/JCO.2003.11.136","journal-title":"J Clin Oncol"},{"issue":"11","key":"5336_CR35","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1634\/theoncologist.2014-0221","volume":"19","author":"Y Takagi","year":"2014","unstructured":"Takagi Y, Hosomi Y, Sunami K, Nakahara Y, Okuma Y, Yomota M, Shimokawa T, Nagamata M, Iguchi M, Okamoto H, Okamura T, Shibuya M (2014) A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer. Oncologist 19(11):1194\u20131199. https:\/\/doi.org\/10.1634\/theoncologist.2014-0221","journal-title":"Oncologist"},{"issue":"2","key":"5336_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.lungcan.2013.04.011","volume":"81","author":"YS Kim","year":"2013","unstructured":"Kim YS, Sun JM, Ahn JS, Ahn MJ, Park K (2013) The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer. Lung Cancer 81(2):231\u2013235. https:\/\/doi.org\/10.1016\/j.lungcan.2013.04.011","journal-title":"Lung Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-020-05336-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T20:53:30Z","timestamp":1613768010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-020-05336-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5336"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05336-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"assertion":[{"value":"24 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ankara University Hospital Ethics board approved the study with the number of 20\u2013644-12.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All healthy subjects gave written informed consent before participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}